Case Reports in Oncological Medicine / 2020 / Article / Fig 3

Case Report

Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis

Figure 3

Timeline of patient’s clinical course highlighting surgical excision, radiation, and MCPyV antibody panel AMERK results for the treatment and management of his MCC, as well as rituximab infusions for his paraneoplastic autoimmune encephalitis. Day 0 is set to his initial MCC diagnosis. Red: diagnoses; blue: AMERK titers; green: treatment interventions for MCC and encephalitis, including wide local excision, IMRT, and rituximab infusions (1 g); black: seizures; purple: latest follow-up scans and EEG.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.